Formulating an Ethics of Pharmaceutical Disinvestment.

Journal of Bioethical Inquiry
Jessica PaceWendy Lipworth

Abstract

There is growing interest among pharmaceutical policymakers in how to "disinvest" from subsidized medicines. This is due to both the rapidly rising costs of healthcare and the increasing use of accelerated and conditional reimbursement pathways which mean that medicines are being subsidized on the basis of less robust evidence of safety and efficacy. It is crucial that disinvestment decisions are morally sound and socially legitimate, but there is currently no framework to facilitate this. We therefore reviewed the bioethics literature in order to identify ethical principles and concepts that might be relevant to pharmaceutical disinvestment decisions. This revealed a number of key ethical considerations-both procedural and substantive-that need to be considered when making pharmaceutical disinvestment decisions. These principles do not, however, provide practical guidance so we present a framework outlining how they might be applied to different types of disinvestment decisions. We also argue that, in this context, even the most rigorous ethical reasoning is likely to be overridden by moral intuitions and psychological biases and that disinvestment decisions will need to strike the right balance between respecting justifiable ...Continue Reading

References

Dec 1, 1994·Journal of Medical Ethics·D P Sulmasy, J Sugarman
Feb 21, 1998·Intensive Care Medicine·G Melltorp, T Nilstun
Nov 14, 2000·JAMA : the Journal of the American Medical Association·M RebagliatoUNKNOWN EURONIC Study Group (European Project on Parents' Information and Ethical Decision Making in Neonatal Intensive Care Units)
Dec 14, 2002·Science·UNKNOWN Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries
May 14, 2003·Social Science & Medicine·John McKie, Jeff Richardson
Oct 27, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Barbara Sibbald
Jul 1, 2005·Critical Care : the Official Journal of the Critical Care Forum·Jean-Louis Vincent
Jan 26, 2008·International Journal of Technology Assessment in Health Care·Adam G ElshaugJohn R Moss
Oct 31, 2008·Health Economics·G Emmanuel Guindon, Paul Contoyannis
Mar 23, 2011·Journal of the National Cancer Institute·John R JohnsonRichard Pazdur
Jul 6, 2012·Bioethics·Dominic Wilkinson, Julian Savulescu
Sep 12, 2012·Social Science & Medicine·Katherine HodgettsJanet E Hiller
Mar 22, 2013·International Journal of Technology Assessment in Health Care·Julie PolisenaBecky Skidmore
Aug 28, 2013·The Journal of Medicine and Philosophy·J S Blumenthal-Barby
Nov 5, 2013·Handbook of Clinical Neurology·Thomas I Cochrane
Jun 25, 2014·Health Policy·Agnes Vitry, Elizabeth Roughead
Sep 10, 2014·Internal Medicine Journal·J R R LewisE Doran
Jan 31, 2015·Social Science & Medicine·Leila RooshenasJenny L Donovan
May 6, 2015·Trends in Cognitive Sciences·Carey K Morewedge, Colleen E Giblin
May 7, 2015·The Hastings Center Report·Rebecca Dresser
Oct 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan R R LewisWendy Lipworth
Oct 21, 2015·Journal of Pharmaceutical Policy and Practice·Agnes VitryElizabeth Roughead
Aug 9, 2016·Healthcare Management Forum·Daniel J NivenHenry T Stelfox
Nov 4, 2016·Healthcare Management Forum·Lesley J J SorilTom W Noseworthy
Apr 4, 2017·Pharmacoepidemiology and Drug Safety·Aaron S KesselheimEric G Campbell
Jul 4, 2017·International Journal of Technology Assessment in Health Care·Massimiliano OrsoAlessandro Montedori
Jul 14, 2017·International Journal of Technology Assessment in Health Care·Mary Alison MaloneyMitchel Levine
Jul 18, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·James D ChambersPeter J Neumann
Dec 27, 2017·International Journal of Technology Assessment in Health Care·Maxine F RobinsonElizabeth Roughead
Jan 11, 2018·The New England Journal of Medicine·Steven Joffe, Holly Fernandez Lynch
Jan 23, 2018·JAMA Internal Medicine·Alison Bateman-House, Christopher T Robertson
Mar 1, 2018·Journal of Medical Ethics·Amy PaulJeremy Sugarman
Mar 1, 2017·Therapeutic Innovation & Regulatory Science·Jessica PaceWendy Lipworth
Mar 14, 2019·The New England Journal of Medicine·J Brian ByrdVivek Bhalla

❮ Previous
Next ❯

Citations

Mar 4, 2020·Journal of Bioethical Inquiry·Narcyz GhineaIan Kerridge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.